Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
10:47:57 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.1742 USD | -3.16% |
|
-7.73% | -23.85% |
| Market Cap | 304M 262M 247M 224M 422M 29.1B 428M 2.89B 1.13B 14.55B 1.14B 1.12B 48.47B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 400M 345M 325M 295M 555M 38.3B 563M 3.81B 1.49B 19.16B 1.5B 1.47B 63.81B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.16% | ||
| 1 week | -7.73% | ||
| Current month | +6.22% | ||
| 1 month | -1.58% | ||
| 3 months | -31.34% | ||
| 6 months | -28.87% | ||
| Current year | -23.85% |
| 1 week | 0.17 |  | 0.21 |
| 1 month | 0.16 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.37 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/29/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 8/9/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.16% | -7.73% | -27.42% | -61.28% | 304M | |
| +0.17% | +4.35% | +72.39% | +114.97% | 73.45B | |
| +1.03% | +15.40% | +57.10% | +92.55% | 62.99B | |
| -0.09% | -2.66% | +1.22% | +485.27% | 28.05B | |
| -1.40% | +4.18% | +54.52% | +19.60% | 25.42B | |
| +20.56% | +22.45% | +1.94% | -3.38% | 23.3B | |
| +2.23% | +5.50% | +41.80% | -13.87% | 19.45B | |
| 0.00% | -4.11% | +243.99% | +423.83% | 18.16B | |
| -3.50% | -0.95% | +17.17% | +534.55% | 16.53B | |
| +2.14% | +7.53% | +44.39% | +153.51% | 13.16B | |
| Average | +1.86% | +2.35% | +50.71% | +174.57% | 28.08B | |
| Weighted average by Cap. | +1.93% | +5.45% | +58.70% | +165.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.63M 31.64M 28.76M 54.08M 3.73B 54.88M 371M 145M 1.87B 146M 143M 6.21B |
| Net income | - | - |
| Net Debt | 96.08M 82.98M 78.08M 70.96M 133M 9.21B 135M 916M 359M 4.6B 361M 353M 15.34B | 125M 108M 102M 92.27M 174M 11.97B 176M 1.19B 467M 5.99B 469M 459M 19.94B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | US$0.1742 | -3.16% | 750,995 |
| 26-08-18 | US$0.1799 | -1.42% | 2,180,304 |
| 26-08-17 | US$0.1825 | -4.95% | 4,396,186 |
| 26-08-14 | US$0.1920 | +1.05% | 1,431,468 |
| 26-08-13 | US$0.1900 | +0.64% | 1,489,846 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1799USD
Average target price
1.000USD
Spread / Average Target
+455.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
